本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cytek BioSciences

4.61
+0.08001.77%
盤後4.610.00000.00%18:19 EDT
成交量:89.77萬
成交額:411.97萬
市值:5.99億
市盈率:-7.32
高:4.64
開:4.61
低:4.49
收:4.53
52周最高:6.18
52周最低:3.28
股本:1.30億
流通股本:1.03億
量比:0.93
換手率:0.87%
股息:- -
股息率:- -
每股收益(TTM):-0.6300
每股收益(LYR):-0.5209
淨資產收益率:-23.04%
總資產收益率:-6.31%
市淨率:1.86
市盈率(LYR):-8.85

資料載入中...

2022/03/02

重要事件披露

8-K - Current report
2022/02/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

重要事件披露

8-K - Current report
2022/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/06

重要事件披露

8-K - Current report
2021/09/02

季度報告

Cytek Biosciences, Inc.
2021/07/29

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

重要事件披露

8-K - Current report
2021/07/27

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/19

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/13

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/02

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933